首页|双歧三联活菌片联合蒙脱石散对腹泻患儿预后的影响

双歧三联活菌片联合蒙脱石散对腹泻患儿预后的影响

扫码查看
目的 探究双歧三联活菌片联合蒙脱石散对腹泻患儿预后的影响.方法 选择江苏省徐州市中心医院儿童诊疗中心2015年10月~2016年12月100例腹泻患儿,采取随机分组的方式,分为对照组与观察组,各50例.对照组采取双歧三联活菌片治疗,观察组采取双歧三联活菌片联合蒙脱石散治疗,对比2组患儿各项指标情况及治疗效果.结果 观察组患儿各项指标情况均优于对照组,差异具有统计学意义(P<0.05).观察组患儿治疗总有效率(98.00%)明显高于对照组(78.00%),差异具有统计学意义(P<0.05).结论 采用双歧三联活菌片联合蒙脱石散治疗腹泻患儿,能够有效改善患儿预后情况,且加快了患儿症状缓解时间,值得应用.
Effect of bifid triple viable tablets combined with montmorillonite powder in the prognosis of children with diarrhea
Objective To study the effect of Bifid Triple Viable tablets combined with montmorillonite powder in the prognosis of children with diarrhea.Methods100 cases of diarrhea patients from October 2015 to December 2016 were selected.The patients were divided into control group and observation group.The control group was treated with Bifid Triple Viable tablets.The observation group was treated with Bifid Triple Viable tablets combined with montmorillonite powder treatment, compared the two groups of patients with the indicators and treatment.ResultsThe indexes of the observation group were better than the control group, the difference between the groups were statistically significant (P<0.05).The total effective rate (98.00%) in the observation group, which was significantly higher than that in the control group (78.00%), the difference between the groups were statistically significant(P<0.05).ConclusionThe combination of Bifid Triple Viable tablets combined with montmorillonite powder in the treatment of diarrhea patients can effectively improve the prognosis of patients and accelerate the remission time of patients, which is worth applying.

bifid triple viable tabletsmontmorillonite powderdiarrheaprognosis

宋晓彤

展开 >

江苏省徐州市中心医院 儿童诊疗中心,江苏 徐州 221000

双歧三联活菌片 蒙脱石散 腹泻 预后

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.37(6)
  • 9
  • 13